RAINBOW
Rainbow Childrens Medicare Limited
Each stock's 10,000-path forecast, rendered as light.
Rainbow Childrens Medicare Limited (RAINBOW) Stock Analysis & Case Study
Is RAINBOW a good buy? The data-driven verdict.
Rainbow Childrens Medicare Limited (RAINBOW) trades at ₹1,557,on the numbers it mixed signals, a Downstox Snapshot Score of 49/100.
On the numbers, Rainbow Childrens Medicare Limited (RAINBOW) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 55.2× earnings, ROE of 15.9%, a 60% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
RAINBOW fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How RAINBOW ranks against the 2,373 companies in our screener
- RAINBOW's market cap of 15,811 Cr ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RAINBOW's book value of ₹162 ranks in the 66th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RAINBOW's promoter holding of 49.8% ranks in the 29th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RAINBOW's 3-year profit (PAT) growth of 6.0% ranks in the 37th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RAINBOW's 3-year revenue growth of 13.0% ranks in the 58th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- RAINBOW's debt-to-equity ratio of 0.54x is lower than 33% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is RAINBOW overvalued? RAINBOW P/E vs peers
RAINBOW trades at 55.2× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
RAINBOW share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 4.2y of RAINBOW history (30%/yr drift, 28%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| RAINBOW 2027 | ₹1,159 | ₹1,678 | ₹2,430 | +8% |
| RAINBOW 2028 | ₹1,072 | ₹1,810 | ₹3,055 | +16% |
| RAINBOW 2029 | ₹1,037 | ₹1,951 | ₹3,671 | +25% |
| RAINBOW 2030 | ₹1,020 | ₹2,104 | ₹4,339 | +35% |
| RAINBOW 2031 | ₹1,000 | ₹2,268 | ₹5,144 | +46% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability RAINBOW goes up, or doubles?
The bull case for RAINBOW
- RAINBOW's return on equity of 15.9% ranks in the 74th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A 10,000-path probability model puts a 60% chance the price is higher in a year, with a median target of ₹1,678 (+8%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹3,671.
The bear case & risks
- RAINBOW's P/E of 55.2x is lower than 24% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 9.6× price-to-book means most of the value is intangible/expectations, not assets on the books.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹1,037.
RAINBOW volatility & expected range, how bumpy is the ride?
Over the last 4.2 years RAINBOW compounded at 30%/year with annualized volatility of 28%. That volatility implies a 1-year 80% range of ₹1,159-₹2,430, the honest backbone behind any single price target.
RAINBOW price forecast, the full 60-month probability fan
RAINBOW price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds RAINBOW hits common targets within the simulated horizon?
Full multi-horizon detail on the RAINBOW price target & forecast page.
RAINBOW Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. RAINBOW scores 6/8, mixed financial health.
RAINBOW MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy RAINBOW with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 28.00% | 3.6× |
| Zerodha | 27.98% | 3.6× |
| Groww | 28.01% | 3.6× |
| Dhan | 27.98% | 3.6× |
| Kotak Neo | 30.03% | 3.3× |
| Paytm Money | 28.04% | 3.6× |
| Pocketful | 28.20% | 3.5× |
| FyersCHEAPEST | 27.78% | 3.6× |
| Anand Rathi | 27.98% | 3.6× |
| Bajaj Broking | 32.00% | 3.1× |
| Share India | 27.99% | 3.6× |
Compare every broker on the RAINBOW MTF page.
About Rainbow Childrens Medicare Limited: sector, index & market-cap context
Rainbow Childrens Medicare Limited (RAINBOW) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹15,811 Cr. See more stocks on our screener.
How the RAINBOW Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Rainbow Childrens Medicare Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
RAINBOW analysis, FAQs
Is Rainbow Childrens Medicare Limited (RAINBOW) a good buy?
On the numbers, Rainbow Childrens Medicare Limited (RAINBOW) mixed signals, a Downstox Snapshot Score of 49/100, weighing expensive at 55.2× earnings, ROE of 15.9%, a 60% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is RAINBOW overvalued or undervalued?
RAINBOW trades at 55.2× earnings, expensive versus the ~22× long-run Nifty average.
What is the RAINBOW share price target for 2031?
RAINBOW's probability-weighted 2031 median target is ₹2,268, with an 80% range of ₹1,000-₹5,144 (10,000-path Monte-Carlo).
What is the probability RAINBOW doubles in 5 years?
The modelled probability of RAINBOW reaching ₹3,113 (2×) within 5 years is 31%.
What is the bull case for RAINBOW?
RAINBOW's return on equity of 15.9% ranks in the 74th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A 10,000-path probability model puts a 60% chance the price is higher in a year, with a median target of ₹1,678 (+8%).
What are the risks in RAINBOW?
RAINBOW's P/E of 55.2x is lower than 24% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 9.6× price-to-book means most of the value is intangible/expectations, not assets on the books.